ORASURE TECHNOLOGIES, INC Foreign Income Tax Expense (Benefit), Continuing Operations
ORASURE TECHNOLOGIES, INC (OSUR) reported Foreign Income Tax Expense (Benefit), Continuing Operations of $26.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-08-07
- ORASURE TECHNOLOGIES, INC foreign income tax expense (benefit), continuing operations for the quarter ending 2026-06-30 was $26.00K.
- ORASURE TECHNOLOGIES, INC foreign income tax expense (benefit), continuing operations for the quarter ending 2026-03-31 was -$463.00K.
- ORASURE TECHNOLOGIES, INC foreign income tax expense (benefit), continuing operations for the quarter ending 2025-12-31 was $69.00K, a 54.00% decline year-over-year.
- ORASURE TECHNOLOGIES, INC foreign income tax expense (benefit), continuing operations for the quarter ending 2025-09-30 was $656.00K, a 0.61% decline year-over-year.
- ORASURE TECHNOLOGIES, INC foreign income tax expense (benefit), continuing operations for fiscal 2025 was -$300.00K, a 121.43% decline from fiscal 2024.
- ORASURE TECHNOLOGIES, INC foreign income tax expense (benefit), continuing operations for fiscal 2024 was $1.40M, a 100.00% increase from fiscal 2023.
- ORASURE TECHNOLOGIES, INC foreign income tax expense (benefit), continuing operations for fiscal 2023 was $700.00K, a 40.00% increase from fiscal 2022.
- ORASURE TECHNOLOGIES, INC foreign income tax expense (benefit), continuing operations for fiscal 2022 was $500.00K, a 96.30% decline from fiscal 2021.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 3 month | Foreign Income Tax Expense (Benefit), Continuing Operations 3 month as first filed | Foreign Income Tax Expense (Benefit), Continuing Operations 6 month | Foreign Income Tax Expense (Benefit), Continuing Operations 9 month | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26.00K 10-Q · filed 2026-08-07 | -$438.00K 10-Q · filed 2026-08-07 | -$368.00K derived: sum of 3 quarters · filed 2026-08-07 | $288.00K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | -$463.00K 10-Q · filed 2026-05-08 | -$394.00K derived: sum of 2 quarters · filed 2026-05-08 | $262.00K derived: sum of 3 quarters · filed 2026-05-08 | -$289.00K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $725.00K derived: sum of 2 quarters · filed 2026-03-09 | $174.00K derived: sum of 3 quarters · filed 2026-08-07 | -$300.00K 10-K · filed 2026-03-09 | ||
| 2025-09-30 | $656.00K 10-Q · filed 2025-11-05 | $105.00K derived: sum of 2 quarters · filed 2026-08-07 | -$369.00K 10-Q · filed 2025-11-05 | -$218.00K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | -$551.00K 10-Q · filed 2026-08-07 | -$1.02M 10-Q · filed 2026-08-07 | -$874.00K derived: sum of 3 quarters · filed 2026-08-07 | -$214.00K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | -$473.00K 10-Q · filed 2026-05-08 | -$323.00K derived: sum of 2 quarters · filed 2026-05-08 | $337.00K derived: sum of 3 quarters · filed 2026-05-08 | $715.00K derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $810.00K derived: sum of 2 quarters · filed 2026-03-09 | $1.19M derived: sum of 3 quarters · filed 2026-03-09 | $1.40M 10-K · filed 2026-03-09 | ||
| 2024-09-30 | $660.00K 10-Q · filed 2025-11-05 | $1.04M derived: sum of 2 quarters · filed 2025-11-05 | $1.25M 10-Q · filed 2025-11-05 | $2.38M derived: sum of 4 quarters · filed 2026-03-09 | ||
| 2024-06-30 | $378.00K 10-Q · filed 2025-08-06 | $591.00K 10-Q · filed 2025-08-06 | $1.72M derived: sum of 3 quarters · filed 2026-03-09 | $2.94M derived: sum of 4 quarters · filed 2026-03-09 | ||
| 2024-03-31 | $212.00K 10-Q · filed 2025-05-07 | $1.34M derived: sum of 2 quarters · filed 2026-03-09 | $2.56M derived: sum of 3 quarters · filed 2026-03-09 | $913.00K derived: sum of 4 quarters · filed 2026-03-09 | ||
| 2023-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.35M derived: sum of 2 quarters · filed 2026-03-09 | $701.00K derived: sum of 3 quarters · filed 2026-03-09 | $700.00K 10-K · filed 2026-03-09 | ||
| 2023-09-30 | $1.22M 10-Q · filed 2024-11-06 | -$431.00K derived: sum of 2 quarters · filed 2024-11-06 | -$432.00K 10-Q · filed 2024-11-06 | $507.00K derived: sum of 4 quarters · filed 2025-03-07 | ||
| 2023-06-30 | -$1.65M 10-Q · filed 2024-08-06 | -$1.65M 10-Q · filed 2023-08-04 | -$1.65M 10-Q · filed 2024-08-06 | -$709.00K derived: sum of 3 quarters · filed 2025-03-07 | -$1.81M derived: sum of 4 quarters · filed 2025-03-07 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $938.00K derived: sum of 2 quarters · filed 2025-03-07 | -$165.00K derived: sum of 3 quarters · filed 2025-03-07 | -$1.52M derived: sum of 4 quarters · filed 2025-03-07 | ||
| 2022-12-31 | $938.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$165.00K derived: sum of 2 quarters · filed 2025-03-07 | -$1.52M derived: sum of 3 quarters · filed 2025-03-07 | $500.00K 10-K · filed 2025-03-07 | $503.00K 10-K · filed 2023-03-03 | |
| 2022-09-30 | -$1.10M 10-Q · filed 2023-11-08 | -$2.46M derived: sum of 2 quarters · filed 2023-11-08 | -$438.00K 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | -$1.35M 10-Q · filed 2023-08-04 | $665.00K 10-Q · filed 2023-08-04 | ||||
| 2022-03-31 | -$1.20M 10-K · filed 2023-03-03 | $2.23M 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | $13.50M 10-K · filed 2024-03-11 | $13.54M 10-K · filed 2022-03-01 | ||||
| 2020-12-31 | $12.19M 10-K · filed 2023-03-03 | |||||
| 2019-12-31 | $4.61M 10-K · filed 2022-03-01 | |||||
| 2018-12-31 | $11.16M 10-K · filed 2021-03-01 | |||||
| 2017-12-31 | $10.08M 10-K · filed 2020-03-02 | |||||
| 2016-12-31 | $353.00K 10-K · filed 2019-02-28 | |||||
| 2016-03-31 | $61.00K 10-Q · filed 2016-05-10 | -$84.00K derived: sum of 2 quarters · filed 2018-02-28 | $63.00K derived: sum of 3 quarters · filed 2018-02-28 | $721.00K derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2015-12-31 | -$145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $2.00K derived: sum of 2 quarters · filed 2018-02-28 | $660.00K derived: sum of 3 quarters · filed 2018-02-28 | $665.00K 10-K · filed 2018-02-28 | ||
| 2015-09-30 | $147.00K 10-Q · filed 2015-11-06 | $805.00K derived: sum of 2 quarters · filed 2015-11-06 | $810.00K 10-Q · filed 2015-11-06 | |||
| 2015-06-30 | $658.00K 10-Q · filed 2015-08-07 | $663.00K 10-Q · filed 2015-08-07 | ||||
| 2015-03-31 | $5.00K 10-Q · filed 2016-05-10 | |||||
| 2014-12-31 | $343.00K 10-K · filed 2017-03-14 | |||||
| 2013-12-31 | $772.00K 10-K · filed 2016-03-14 | |||||
| 2012-12-31 | -$1.40M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |